U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H12F2N6
Molecular Weight 374.3463
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JNJ-38877618

SMILES

FC(F)(C1=NN=C2C=CC(=NN12)C3=CC=NC=C3)C4=CC5=C(C=C4)N=CC=C5

InChI

InChIKey=KOAWAWHSMVKCON-UHFFFAOYSA-N
InChI=1S/C20H12F2N6/c21-20(22,15-3-4-16-14(12-15)2-1-9-24-16)19-26-25-18-6-5-17(27-28(18)19)13-7-10-23-11-8-13/h1-12H

HIDE SMILES / InChI

Molecular Formula C20H12F2N6
Molecular Weight 374.3463
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1372 ng/mL
250 mg 2 times / day multiple, oral
dose: 250 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
JNJ-38877618 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
5684 ng × h/mL
250 mg 2 times / day multiple, oral
dose: 250 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
JNJ-38877618 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
2.75 h
250 mg 2 times / day multiple, oral
dose: 250 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
JNJ-38877618 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Substance Class Chemical
Created
by admin
on Tue Apr 01 17:24:47 GMT 2025
Edited
by admin
on Tue Apr 01 17:24:47 GMT 2025
Record UNII
E0B2IZB5H5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
JNJ-38877618
Code English
JNJ38877618
Preferred Name English
OMO-1
Code English
OMO1
Code English
6-(DIFLUORO-(6-(4-PYRIDYL)-(1,2,4)TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)METHYL)QUINOLINE
Systematic Name English
QUINOLINE, 6-(DIFLUORO(6-(4-PYRIDINYL)-1,2,4-TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)METHYL)-
Systematic Name English
OMO 1 [WHO-DD]
Common Name English
Code System Code Type Description
CAS
943540-74-7
Created by admin on Tue Apr 01 17:24:47 GMT 2025 , Edited by admin on Tue Apr 01 17:24:47 GMT 2025
PRIMARY
NCI_THESAURUS
C148537
Created by admin on Tue Apr 01 17:24:47 GMT 2025 , Edited by admin on Tue Apr 01 17:24:47 GMT 2025
PRIMARY
FDA UNII
E0B2IZB5H5
Created by admin on Tue Apr 01 17:24:47 GMT 2025 , Edited by admin on Tue Apr 01 17:24:47 GMT 2025
PRIMARY
PUBCHEM
57654476
Created by admin on Tue Apr 01 17:24:47 GMT 2025 , Edited by admin on Tue Apr 01 17:24:47 GMT 2025
PRIMARY
SMS_ID
300000042483
Created by admin on Tue Apr 01 17:24:47 GMT 2025 , Edited by admin on Tue Apr 01 17:24:47 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY
Originator: Janssen-Cilag; Mechanism of Action: Proto oncogene protein c met inhibitor; Orphan Drug Status: No; On Fast track: No; New Molecular Entity: Yes; Highest Development Phase: Phase I for Cancer; Most Recent Event: 15 Oct 2013 Janssen-Cilag plans a phase I trial for Healthy volunteers in the UK (NCT01964872)